Clinical trial
Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon…
NCT00031018 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00031018 |
|---|---|
| Title | Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha |
| Official title | Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Memory Disorders, Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Aricept, IFN-alpha2A |
| First posted | Feb 22, 2002 |
| Last update posted | Feb 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: